Technical Note: Single time point dose estimate for exponential clearance. 2018

Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
Department of Radiology, University of Iowa, Iowa City, IA, 52242, USA.

OBJECTIVE Although personalized dosimetry may be desirable for radionuclide therapy treatments, the multiple time samples required to determine the total integrated activity puts a burden on patients and clinic resources. The aim of this paper is to demonstrate that when some prior knowledge is known about the tracer kinetic parameters, the total integrated activity (and thus radiation dose) can be estimated from a single time sample. METHODS Mathematical derivations have been performed to generate equations for the total integrated activity in terms of a single time sample of activity for monoexponential and biexponential clearance. Simulations were performed using both exponential models where the rate constants and associated parameters were randomly sampled from distributions with a known mean. The actual total integrated activity for each random sample was compared with the estimated total integrated activity using the mean value of the parameters. Retrospective analysis of 90 Y DOTATOC data from a clinical trial provided a comparison of actual kidney dose with the estimated kidney dose using the single time point approach. RESULTS The optimal sampling time for the single point approach was found to be equal to the mean time of the rate constant. The simulation results for the monoexponential and biexpoential models were similar. Regressions comparing the actual and estimated total integrated activity had very high correlations (r2  > 0.95) along with acceptable standard errors of estimate, especially at the optimal sampling point. The retrospective analysis of the 90 Y DOTATOC data also yielded similar results with an r2  = 0.95 and a standard error of estimate of 61 cGy. CONCLUSIONS In situations where there is prior knowledge about the population averages of kinetic parameters, these results suggest that the single time point approach can be used to estimate the total integrated activity and dose with sufficient accuracy to manage radionuclide therapy. This will make personalized dosimetry much easier to perform and more available to the community.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011849 Radioactive Tracers Radioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. (Hawley's Condensed Chemical Dictionary, 12th ed) Radioactive Tracer,Radionuclide Tracer,Radionuclide Tracers,Tracer, Radioactive,Tracer, Radionuclide,Tracers, Radioactive,Tracers, Radionuclide
D011874 Radiometry The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING. Geiger-Mueller Counters,Nuclear Track Detection,Radiation Dosimetry,Dosimetry, Radiation,Geiger Counter,Geiger-Mueller Counter Tube,Geiger-Mueller Probe,Geiger-Mueller Tube,Radiation Counter,Counter Tube, Geiger-Mueller,Counter Tubes, Geiger-Mueller,Counter, Geiger,Counter, Radiation,Counters, Geiger,Counters, Geiger-Mueller,Counters, Radiation,Detection, Nuclear Track,Dosimetries, Radiation,Geiger Counters,Geiger Mueller Counter Tube,Geiger Mueller Counters,Geiger Mueller Probe,Geiger Mueller Tube,Geiger-Mueller Counter Tubes,Geiger-Mueller Probes,Geiger-Mueller Tubes,Probe, Geiger-Mueller,Probes, Geiger-Mueller,Radiation Counters,Radiation Dosimetries,Tube, Geiger-Mueller,Tube, Geiger-Mueller Counter,Tubes, Geiger-Mueller,Tubes, Geiger-Mueller Counter
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D057285 Precision Medicine Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile. Individualized Medicine,Predictive Medicine,P Health,P-Health,Personalized Medicine,Theranostics,Medicine, Individualized,Medicine, Personalized,Medicine, Precision,Medicine, Predictive,Theranostic

Related Publications

Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
June 2019, Medical physics,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
November 2023, Medical physics,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
September 1979, Research communications in chemical pathology and pharmacology,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
October 1986, International journal of clinical pharmacology, therapy, and toxicology,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
March 2023, Medical physics,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
January 1982, Therapeutic drug monitoring,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
January 1999, IEEE transactions on neural networks,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
November 2020, Medical physics,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
November 2021, Medical physics,
Mark T Madsen, and Yusuf Menda, and Thomas M O'Dorisio, and M Sue O'Dorisio
October 2016, Medical physics,
Copied contents to your clipboard!